<DOC>
	<DOC>NCT00534859</DOC>
	<brief_summary>The objective of this feasibility study is to demonstrate that the device is safe and potentially efficacious for use in patients undergoing high risk Percutaneous Coronary Interventions(PCI).Patients will be enrolled if they meet inclusion &amp; exclusion criteria.</brief_summary>
	<brief_title>PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI</brief_title>
	<detailed_description />
	<criteria>Signed Informed Consent Non emergent PCI of at least one de novo or restenotic lesion in a native coronary vessel or bypass graft EF &lt;35% ST Myocardial Infarction Cardiac Arrest Cardiogenic Shock Thrombus Left Ventricle</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>